Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Coenzyme Q10
Selected research topic
Women's health
Some measured outcomes improved in human comparison studies. Read these findings with their populations and conditions.
Some findings concern patients or people with a deficiency.
- Publications for this topic
- 3
- Human comparison publications
- 1
- Publications needing review
- 1
Findings in the studies
serum total testosterone levels
- A better result than the comparison group was reported.Patient group · Separable contribution · 8 weeks
Measurement and study conditions
- Study type
- Randomized controlled trial: subjects were randomly assigned to groups for comparison.
- Study population
- Human participants · Patient group
- Ingredients tested
- Separable contribution
- How results were compared
- Results were compared between groups. · Study comparison: CoQ10-containing arms (CoQ10 alone and CoQ10+vitamin E) vs placebo
- Additional measurement information
- Secondary outcome
- Measurement time
- 8 weeks
oocyte count
Other human research, including observational studies and reviews
- A change was reported, but the comparison could not be confirmed.Patient group · Single ingredient
Measurement and study conditions
- Study type
- Randomized controlled trial: subjects were randomly assigned to groups for comparison.
- Study population
- Human participants · Patient group
- Ingredients tested
- Single ingredient
- Measurement time
- Not confirmed.
Representative outcome and study details
Human studies reported a change with no confirmed comparison group in oocyte count.
Single-ingredient studies · Human studies · Includes patient groups · comparator not confirmed
1 publications linked to this result
- Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: B
The 54.4 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 113
Papers linked to this topic 3 · distinct papers 3 · papers with a confirmed human comparison 1 · papers needing additional review 1
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
- oocyte count: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- serum total testosterone levels: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
What the research found
serum total testosterone levels
The study reported improvement in this measurement.
Controlled study in people · Separable contribution · Patient group
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
oocyte count
A change was reported, but the comparison could not be confirmed.
Controlled study in people · Single ingredient · Patient group
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
Unspecified measured outcome
The study needs further checking before its result can be interpreted.
Other evidence · Single ingredient · Unspecified population
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
How to read research findings
How should I read research findings?
Research guidesNo clear difference and an uninterpretable result are different
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Paper counts and study counts are different
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Side effects and combination findings
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No combination cautions are available to show in the current data. This does not guarantee safety.
Review 2 combination findings and 0 findings that outperformed an ingredient alone.
Reported improvements with combinations
Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.
Combinations with reported improvement
The combination showed improvement, but each ingredient's contribution is unclear.
CurcuminThe study suggests a possible synergistic effect of nano-curcumin and CoQ10 on clinical features of migraine compared to monotherapy or placebo.
SeleniumCombined supplementation with selenium and Coenzyme Q10 resulted in significantly improved renal function markers compared to placebo.